Maldonado R - Search Results

1

Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.

Maldonado R, Valverde O, Derrien M, Tejedor-Real P, Roques BP. Maldonado R, et al. Pharmacol Biochem Behav. 1994 Jun;48(2):363-9. doi: 10.1016/0091-3057(94)90539-8. Pharmacol Biochem Behav. 1994. PMID: 8090802

2

Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice.

Valverde O, Micó JA, Maldonado R, Gibert-Rahola J. Valverde O, et al. Among authors: maldonado r. Drug Alcohol Depend. 1992 Aug;30(3):293-300. doi: 10.1016/0376-8716(92)90064-j. Drug Alcohol Depend. 1992. PMID: 1327709

3

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes.

Fournié-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Maldonado R, Roques BP. Fournié-Zaluski MC, et al. Among authors: maldonado r. J Med Chem. 1992 Jun 26;35(13):2473-81. doi: 10.1021/jm00091a016. J Med Chem. 1992. PMID: 1352352

4

Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.

Maldonado R, Fournié-Zaluski MC, Roques BP. Maldonado R, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):466-72. doi: 10.1007/BF00176626. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1620246

5

Influence of different benzodiazepines on the experimental morphine abstinence syndrome.

Maldonado R, Micó JA, Valverde O, Saavedra MC, Leonsegui I, Gibert-Rahola J. Maldonado R, et al. Psychopharmacology (Berl). 1991;105(2):197-203. doi: 10.1007/BF02244309. Psychopharmacology (Berl). 1991. PMID: 1686654

6

Effects induced by chronic treatment with selective D1 or D2 antagonists on open-field behavior and colonic temperature.

Maldonado R, Baamonde A, Daugé V, Féger J. Maldonado R, et al. Fundam Clin Pharmacol. 1990;4(3):341-56. doi: 10.1111/j.1472-8206.1990.tb00498.x. Fundam Clin Pharmacol. 1990. PMID: 2142927

7

Naloxone-induced withdrawal syndrome after administration of selective opioid agonists or after activation of the endogenous enkephalinergic system.

Maldonado R, Waksman G, Feger J, Roques BP. Maldonado R, et al. Prog Clin Biol Res. 1990;328:531-4. Prog Clin Biol Res. 1990. PMID: 2154817 No abstract available.

8

Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.

Maldonado R, Daugé V, Feger J, Roques BP. Maldonado R, et al. Neuropharmacology. 1990 Mar;29(3):215-23. doi: 10.1016/0028-3908(90)90004-b. Neuropharmacology. 1990. PMID: 2157999

9

Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.

Maldonado R, Feger J, Fournié-Zaluski MC, Roques BP. Maldonado R, et al. Brain Res. 1990 Jun 18;520(1-2):247-54. doi: 10.1016/0006-8993(90)91712-p. Brain Res. 1990. PMID: 2169953

10

Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome.

Maldonado R, Daugé V, Callebert J, Villette JM, Fournié-Zaluski MC, Feger J, Roques BP. Maldonado R, et al. Eur J Pharmacol. 1989 Jun 20;165(2-3):199-207. doi: 10.1016/0014-2999(89)90713-9. Eur J Pharmacol. 1989. PMID: 2776828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters